Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries.
作者信息
Miller Kellee M, Hermann Julia, Foster Nicole, Hofer Sabine E, Rickels Michael R, Danne Thomas, Clements Mark A, Lilienthal Eggert, Maahs David M, Holl Reinhard W
机构信息
Jaeb Center for Health Research, Tampa, FL
Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
出版信息
Diabetes Care. 2020 Jan;43(1):e1-e2. doi: 10.2337/dc19-1214. Epub 2019 Oct 31.
Abstract
摘要
相似文献
1
Longitudinal Changes in Continuous Glucose Monitoring Use Among Individuals With Type 1 Diabetes: International Comparison in the German and Austrian DPV and U.S. T1D Exchange Registries.
Diabetes Care. 2020 Jan;43(1):e1-e2. doi: 10.2337/dc19-1214. Epub 2019 Oct 31.
2
Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
Pediatr Diabetes. 2018 Nov;19(7):1271-1275. doi: 10.1111/pedi.12711. Epub 2018 Jul 1.
3
Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries.
Diabetes Res Clin Pract. 2016 Dec;122:28-37. doi: 10.1016/j.diabres.2016.09.024. Epub 2016 Oct 4.
4
Low prevalence of patients with mitochondrial disease in the German/Austrian DPV diabetes registry.
Eur J Pediatr. 2016 May;175(5):613-22. doi: 10.1007/s00431-015-2675-5. Epub 2015 Dec 15.
5
Longitudinal trajectories of BMI z-score: an international comparison of 11,513 Australian, American and German/Austrian/Luxembourgian youth with type 1 diabetes.
Pediatr Obes. 2020 Feb;15(2):e12582. doi: 10.1111/ijpo.12582. Epub 2019 Nov 5.
6
Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries.
Diabetes Obes Metab. 2020 Sep;22(9):1577-1585. doi: 10.1111/dom.14069. Epub 2020 May 19.
7
Diabetes in Patients with ß-thalassemia or other Hemoglobinopathies - Analysis from the DPV Database.
Klin Padiatr. 2016 Nov;228(6-07):307-312. doi: 10.1055/s-0042-111691. Epub 2016 Nov 15.
8
Asthma in children and adolescents with type 1 diabetes in Germany and Austria: Frequency and metabolic control.
Pediatr Diabetes. 2018 Jun;19(4):727-732. doi: 10.1111/pedi.12618. Epub 2017 Dec 8.
9
Standardized Documentation in Pediatric Diabetology: Experience From Austria and Germany.
J Diabetes Sci Technol. 2016 Aug 22;10(5):1042-9. doi: 10.1177/1932296816658057. Print 2016 Sep.
10
Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injection therapy: data from the German/Austrian DPV registry. Reply to Rigalleau et al.
Diabet Med. 2020 Jul;37(7):1209-1210. doi: 10.1111/dme.14311. Epub 2020 May 3.
引用本文的文献
1
Global Inequities in Diabetes Technology and Insulin Access and Glycemic Outcomes.
JAMA Netw Open. 2025 Aug 1;8(8):e2528933. doi: 10.1001/jamanetworkopen.2025.28933.
2
Race and ethnic disparities in insulin pump and continuous glucose monitor use between 2017 and 2024: a systematic review with a focus on health equity.
J Health Equity. 2025;2(1). doi: 10.1080/29944694.2024.2444002. Epub 2025 Feb 13.
3
Accuracy of a 15-day Factory-Calibrated Continuous Glucose Monitoring System With Improved Sensor Design.
J Diabetes Sci Technol. 2025 Apr 4:19322968251329364. doi: 10.1177/19322968251329364.
4
International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024 Diabetes Technologies: Glucose Monitoring.
Horm Res Paediatr. 2024;97(6):615-635. doi: 10.1159/000543156. Epub 2025 Jan 30.
5
What is the Relationship Between Time in Range, Time in Tight Range, and HbA1c in Youth and Young Adults With Type 1 Diabetes? Results From the German/Austrian/Luxembourgian/Swiss Diabetes Prospective Follow-Up Registry.
J Diabetes Sci Technol. 2024 Nov 16:19322968241288870. doi: 10.1177/19322968241288870.
6
Controlling spheroid attachment improves pancreatic beta cell differentiation from human iPS cells.
In Vitro Cell Dev Biol Anim. 2024 Nov 15. doi: 10.1007/s11626-024-00991-3.
7
Recent Advances in Amperometric Biosensors for Medical Applications: A Mini-Review.
Curr Top Med Chem. 2025;25(7):741-760. doi: 10.2174/0115680266323004241015122441.
8
Psychosocial Aspects of Diabetes Technologies: Commentary on the Current Status of the Evidence and Suggestions for Future Directions.
J Diabetes Sci Technol. 2025 Jan;19(1):27-33. doi: 10.1177/19322968241276550. Epub 2024 Oct 21.
9
Can a mobile application improve glucose-related and patient-reported outcome measures (PROMs) in people with type 1 diabetes mellitus? A randomized controlled trial using the mySugr app.
Hormones (Athens). 2025 Mar;24(1):137-147. doi: 10.1007/s42000-024-00609-z. Epub 2024 Oct 16.
10
Discordance Between Clinician and Person-With-Diabetes Perceptions Regarding Technology Barriers and Benefits.
J Diabetes Sci Technol. 2025 Jan;19(1):18-26. doi: 10.1177/19322968241285045. Epub 2024 Oct 6.
本文引用的文献
1
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018.
Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089/dia.2018.0384. Epub 2019 Jan 18.
2
Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
Pediatr Diabetes. 2018 Nov;19(7):1271-1275. doi: 10.1111/pedi.12711. Epub 2018 Jul 1.
3
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
N Engl J Med. 2008 Oct 2;359(14):1464-76. doi: 10.1056/NEJMoa0805017. Epub 2008 Sep 8.
Zotero 插件